AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Explore Visa credit cards that combine no annual fees with cashback rewards. Enjoy savings on every purchase.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A high-profile Ethereum MEV exploit tied to the Jaredfromsubway bot has seen the attacker move millions via Tornado C...
OpenAI's planned IPO faces a timing change that could redefine AI stock bets. The shift underscores a tougher funding...
In 2026, dividend aristocrats quietly outrunning software stocks has drawn fresh money into income-focused ETFs as vo...
Intel pursues a renewed foundry strategy and AI-focused growth as investors weigh the company’s turnaround. The marke...
Bitcoin and Ethereum hold firm as stablecoins drop more than $10B since May, signaling a shift toward memecoins. Regu...
Regulators miss GENIUS Act's one-year deadline for final stablecoin rules, while the 2027 effective date stays in pla...
Washington asserts that existing tariff pacts stay in force even after a Supreme Court setback. The stance draws mixe...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
Lenovo’s Global CIO says patience stays key for AI investments even as enterprise demand accelerates and hardware pri...
Polymarket is adopting an AI-driven monitoring system from Palantir and TWG Global to police betting activity in real...
A dramatic 72% decline in a key internet infrastructure stock drew a bold $12 million investment. This article explai...